WCBA
DBD

Weaver C. Barksdale & Associates’s Diebold Nixdorf Incorporated DBD Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio DBD Stock Details DBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$24K Buy
1,480
+380
+35% +$7.35K 0.03% 145
2017
Q3 		$25K Buy
1,100
+324
+42% +$6.9K 0.03% 137
2017
Q2 		$22K Buy
776
+166
+27% +$4.59K 0.03% 148
2017
Q1 		$19K Hold
610
– – 0.02% 165
2016
Q4 		$15K Buy
610
+156
+34% +$3.68K 0.02% 199
2016
Q3 		$11K Buy
454
+30
+7% +$797 0.02% 249
2016
Q2 		$11K Hold
424
– – 0.02% 225
2016
Q1 		$12K Buy
424
+36
+9% +$941 0.01% 238
2015
Q4 		$12K Sell
388
-25
-6% -$849 0.01% 228
2015
Q3 		$12K Buy
413
+41
+11% +$1.33K 0.01% 227
2015
Q2 		$13K Sell
372
-23
-6% -$811 0.01% 230
2015
Q1 		$14K Buy
395
+27
+7% +$910 0.01% 219
2014
Q4 		$13K Buy
368
+20
+6% +$705 0.01% 217
2014
Q3 		$12K Buy
348
+23
+7% +$868 0.01% 228
2014
Q2 		$13K Buy
325
+16
+5% +$614 0.01% 226
2014
Q1 		$12K Sell
309
-56
-15% -$2.02K 0.01% 229
2013
Q4 		$12K Sell
365
-27
-7% -$842 0.01% 245
2013
Q3 		$12K Buy
392
+26
+7% +$815 0.01% 240
2013
Q2 		$12K Buy
+366
New +$11.3K 0.01% 238

Other funds holding DBD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SAM
Southernsun Asset Management Memphis, Tennessee $690M AUM 30.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
Atlantic Investment Management New York $172M AUM 39.5% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Weaver C. Barksdale & Associates's DBD Position: Q4 2017 in Review

Weaver C. Barksdale & Associates increased its Diebold Nixdorf Incorporated (DBD) stake by 35% in Q4 2017, buying an estimated $7.35K and bringing the position to 1,480 shares worth $24K. The position accounts for 0.03% of the portfolio, ranked #145.

Weaver C. Barksdale & Associates first reported a position in DBD in Q2 2013 and has held it in 19 quarters since. The position peaked at $25K in Q3 2017. 254 funds tracked by Wall St. Rank hold DBD as of Q4 2017.

  • Weaver C. Barksdale & Associates held 1,480 shares of Diebold Nixdorf Incorporated worth $24K as of Q4 2017.
  • Weaver C. Barksdale & Associates bought 380 Diebold Nixdorf Incorporated shares in Q4 2017, an estimated $7.35K.
  • Diebold Nixdorf Incorporated made up 0.03% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #145 holding.
  • Weaver C. Barksdale & Associates first reported a position in Diebold Nixdorf Incorporated in Q2 2013 and has held it in 19 quarters since.
  • Weaver C. Barksdale & Associates's Diebold Nixdorf Incorporated position peaked at $25K in Q3 2017.
  • 254 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.